We're developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications.
Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. We're combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.
Company Details
- Employees
- 10
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neuroharmonics.com
- Keywords
- IT Consulting.
- HQ
- London
Neuroharmonics Questions
Neuroharmonics's website is http://www.neuroharmonics.com
Neuroharmonics's LinkedIn profile is https://uk.linkedin.com/company/neuroharmonics
Neuroharmonics has
10 employees.
View email and phone details for 10
employees at Neuroharmonics.
Neuroharmonics's industry is
Biotechnology Research
Neuroharmonics's top competitors are
Attune Neurosciences, Inc.,
Vave Health,
Humanoid,
Precision Neuroscience,
Demetria Ltd,
Nudge,
Pometry,
Intelligyn,
Sonalis Imaging,
Samphire Neuroscience.
Neuroharmonics's categories are Biotechnology Research
Neuroharmonics's founding year is 2024
